Advertisement

Topics

US FDA approves Gilead's once─daily oral Truvada for reducing risk of acquiring HIV─1 in adolescents

13:42 EDT 17 May 2018 | PharmaBiz

Gilead Sciences, Inc. announced that the US Food and Drug Administration (FDA) has approved once─daily oral Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)──in combination with safer sex practices

Original Article: US FDA approves Gilead's once─daily oral Truvada for reducing risk of acquiring HIV─1 in adolescents

NEXT ARTICLE

More From BioPortfolio on "US FDA approves Gilead's once─daily oral Truvada for reducing risk of acquiring HIV─1 in adolescents"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...